nach oben

Erschienen in:

01.08.2023 | Brief Report

Molecular evolution of dengue virus: a Bayesian approach using 1581 whole-genome sequences from January 1944 to July 2022

verfasst von: Jonas Wolf, Ana Paula de Souza, Raine Fogliati de Carli Schardosim, Arthur Pille, Juçara Gasparetto Maccari, Mohamed Parrini Mutlaq, Luiz Antonio Nasi

Erschienen in: Archives of Virology | Ausgabe 8/2023

Einloggen, um Zugang zu erhalten

Abstract

Dengue is a viral disease transmitted by mosquitoes that has spread rapidly across all continents in recent years. There are four distinct but closely related serotypes of the virus that causes dengue (DENV-1, DENV-2, DENV-3, and DENV-4). In the present study, we evaluated temporal spreading and molecular evolution of dengue virus (DENV) serotypes. Bayesian coalescent analysis was performed to study viral evolution, and it was estimated that the most recent common ancestor of DENV-1 was present in 1884 in Southeast Asia, that of DENV-2 was present in 1723 in Europe, that of DENV-3 was present in 1921 in Southeast Asia, and that of DENV-4 was present in 1876 in Southeast Asia. DENV appears to have originated in Spain in approximately 1682, and it was disseminated in Asia and Oceania in approximately 1847. After this period, the virus was introduced into North America in approximately 1890. In South America, it was first disseminated to Ecuador in approximately 1897 and then to Brazil in approximately 1910. Dengue has had a significant impact on global health worldwide, and the present study provides an overview of the molecular evolution of DENV serotypes.

Nur mit Berechtigung zugänglich

Nanaware N, Banerjee A, Mullick Bagchi S, Bagchi P, Mukherjee A (2021) Dengue virus infection: a tale of viral exploitations and host responses. Viruses 13(10):1967. https://doi.org/10.3390/v13101967CrossRefPubMedPubMedCentral

WHO (2009) Dengue Guidelines for Diagnosis, Treatment, Prevention and Control: New Edition. World Health Organization. https://apps.who.int/iris/handle/10665/44188

Shepard DS, Undurraga EA, Halasa YA, Stanaway JD (2016) The global economic burden of dengue: a systematic analysis. Lancet Infect Dis 16(8):935–941. https://doi.org/10.1016/S1473-3099(16)00146-8CrossRefPubMed

Rico-Hesse R (1990) Molecular evolution and distribution of dengue viruses type 1 and 2 in nature. Virology 174(2):479–493. https://doi.org/10.1016/0042-6822(90)90102-WCrossRefPubMed

Messina JP, Brady OJ, Scott TW et al (2014) Global spread of dengue virus types: mapping the 70 year history. Trends Microbiol 22(3):138–146. https://doi.org/10.1016/j.tim.2013.12.011CrossRefPubMedPubMedCentral

Hotta S (1952) Experimental studies on dengue. I. Isolation, identification and modification of the virus. J Infect Dis 90(1):1–9. https://doi.org/10.1093/INFDIS/90.1.1CrossRefPubMed

Vasilakis N, Weaver SCBTA (2008) in VR. Chapter 1 The History and Evolution of Human Dengue Emergence. In: Advances in Virus Research. Vol 72. Academic Press; :1–76. doi:https://doi.org/10.1016/S0065-3527(08)00401-6

Harapan H, Michie A, Sasmono RT, Imrie A, Dengue (2020) A Minireview Viruses 12(8):829. https://doi.org/10.3390/v12080829CrossRefPubMed

Choudhury MA, Lott WB, Aaskov J (2014) Distribution of Fitness in Populations of Dengue Viruses. Coffey LL, ed. PLoS One. ;9(9):e107264. doi:https://doi.org/10.1371/journal.pone.0107264

10.

Mustafa MS, Rasotgi V, Jain S, Gupta V (2015) Discovery of fifth serotype of dengue virus (DENV-5): A new public health dilemma in dengue control. Med J Armed Forces India 71(1):67–70. https://doi.org/10.1016/j.mjafi.2014.09.011CrossRefPubMed

11.

Katzelnick LC, Coloma J, Harris E (2017) Dengue: knowledge gaps, unmet needs, and research priorities. Lancet Infect Dis 17(3):e88–e100. https://doi.org/10.1016/S1473-3099(16)30473-XCrossRefPubMedPubMedCentral

12.

Chen R, Vasilakis N (2011) Dengue — Quo tu et quo vadis? Viruses 3(9):1562–1608. https://doi.org/10.3390/v3091562CrossRefPubMedPubMedCentral

13.

Hadfield J, Megill C, Bell SM et al (2018) Nextstrain: real-time tracking of pathogen evolution. Kelso J, ed. Bioinformatics. ;34(23):4121–4123. doi:https://doi.org/10.1093/bioinformatics/bty407

14.

Kumar G, Ertel A, Feldman G, Kupper J, Fortina P (2020) iSeqQC: a tool for expression-based quality control in RNA sequencing. BMC Bioinformatics 21(1):56. https://doi.org/10.1186/s12859-020-3399-8CrossRefPubMedPubMedCentral

15.

Sagulenko P, Puller V, Neher RA, TreeTime (2018) Maximum-likelihood phylodynamic analysis. Virus Evol 4(1). https://doi.org/10.1093/ve/vex042

16.

Robert E, Kass, Adrian E Raftery. Bayes Factors, J Am Stat Assoc. 90:430, 773–795, DOI: https://doi.org/10.1080/01621459.1995.10476572

17.

Navero-Castillejos J, Benitez R, Torner N et al (2021) Molecular Characterization of Imported and Autochthonous Dengue in Northeastern Spain. Viruses 13(10):1910. https://doi.org/10.3390/v13101910CrossRefPubMedPubMedCentral

18.

Redondo-Bravo L, Ruiz-Huerta C, Gomez-Barroso D, Sierra-Moros MJ, Benito A, Herrador Z (2019) Imported dengue in Spain: a nationwide analysis with predictive time series analyses. J Travel Med 26(8). https://doi.org/10.1093/jtm/taz072

19.

Stica CJ, Barrero RA, Murray RZ, Devine GJ, Phillips MJ, Frentiu FD (2022) Global Evolutionary History and Dynamics of Dengue Viruses Inferred from Whole Genome Sequences. Viruses 14(4):703. https://doi.org/10.3390/v14040703CrossRefPubMedPubMedCentral

20.

Wei K, Li Y (2017) Global evolutionary history and spatio-temporal dynamics of dengue virus type 2. Sci Rep 7(1):45505. https://doi.org/10.1038/srep45505CrossRefPubMedPubMedCentral

21.

Walimbe AM, Lotankar M, Cecilia D, Cherian SS (2014) Global phylogeography of Dengue type 1 and 2 viruses reveals the role of India. Infect Genet Evol 22:30–39. https://doi.org/10.1016/j.meegid.2014.01.001CrossRefPubMed

22.

Costa RL, Voloch CM, Schrago CG (2012) Comparative evolutionary epidemiology of dengue virus serotypes. Infect Genet Evol 12(2):309–314. https://doi.org/10.1016/J.MEEGID.2011.12.011CrossRefPubMed

23.

Kariyawasam R, Lachman M, Mansuri S, Chakrabarti S, Boggild AK A dengue vaccine whirlwind update. Ther Adv Infect Dis 20;10:20499361231167274. doi: https://doi.org/10.1177/20499361231167274

24.

Stolerman LM, Maia PD, Kutz JN (2019) Forecasting dengue fever in Brazil: An assessment of climate conditions. Samy AM, ed. PLoS One. ;14(8):e0220106. doi:https://doi.org/10.1371/journal.pone.0220106

Titel: Molecular evolution of dengue virus: a Bayesian approach using 1581 whole-genome sequences from January 1944 to July 2022
verfasst von: Jonas Wolf
Ana Paula de Souza
Raine Fogliati de Carli Schardosim
Arthur Pille
Juçara Gasparetto Maccari
Mohamed Parrini Mutlaq
Luiz Antonio Nasi
Publikationsdatum: 01.08.2023
Verlag: Springer Vienna
Erschienen in: Archives of Virology / Ausgabe 8/2023
Print ISSN: 0304-8608
Elektronische ISSN: 1432-8798
DOI: https://doi.org/10.1007/s00705-023-05833-3

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

„Jeder Fall von plötzlichem Tod muss obduziert werden!“

17.05.2024 Plötzlicher Herztod Nachrichten

Ein signifikanter Anteil der Fälle von plötzlichem Herztod ist genetisch bedingt. Um ihre Verwandten vor diesem Schicksal zu bewahren, sollten jüngere Personen, die plötzlich unerwartet versterben, ausnahmslos einer Autopsie unterzogen werden.

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

17.05.2024 Direkte orale Antikoagulanzien Nachrichten

Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.

Schlechtere Vorhofflimmern-Prognose bei kleinem linken Ventrikel

17.05.2024 Vorhofflimmern Nachrichten

Nicht nur ein vergrößerter, sondern auch ein kleiner linker Ventrikel ist bei Vorhofflimmern mit einer erhöhten Komplikationsrate assoziiert. Der Zusammenhang besteht nach Daten aus China unabhängig von anderen Risikofaktoren.

Semaglutid bei Herzinsuffizienz: Wie erklärt sich die Wirksamkeit?

17.05.2024 Herzinsuffizienz Nachrichten

Bei adipösen Patienten mit Herzinsuffizienz des HFpEF-Phänotyps ist Semaglutid von symptomatischem Nutzen. Resultiert dieser Benefit allein aus der Gewichtsreduktion oder auch aus spezifischen Effekten auf die Herzinsuffizienz-Pathogenese? Eine neue Analyse gibt Aufschluss.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Die Highlights vom Kongress des American College of Cardiology 2024

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 8/2023

Evidence of insufficient genetic data and lack of regular genetic research on rabies virus in the Russian Federation: a study of the recent epizootic situation

Phylogenotyping of infectious bursal disease virus in Vietnam according to the newly unified genotypic classification scheme

The attenuated live vaccine strain W2512 provides protection against novel variant infectious bursal disease virus

Clinical and molecular epidemiologic features of enterovirus D68 infection in children with acute lower respiratory tract infection in China

In vitro propagation of infectious hypodermal hematopoietic necrosis virus (Penaeus stylirostris penstyldensovirus) in PmLyO-Sf9 cells

Correction to: Molecular evolution of dengue virus: a Bayesian approach using 1581 whole-genome sequences from January 1944 to July 2022